Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -246,283 | -67,851 | -84,263 | -83,221 | -46,139 |
| Depreciation Amortization | 24,810 | 9,101 | 6,724 | 5,565 | 3,980 |
| Income taxes - deferred | N/A | -1,597 | N/A | N/A | N/A |
| Accounts receivable | -5,463 | -7,389 | -22,903 | -9,292 | -2,786 |
| Accounts payable and accrued liabilities | 505 | 4,341 | 5,046 | 1,250 | 2,145 |
| Other Working Capital | -47,665 | -8,303 | -1,127 | -4,989 | 2,454 |
| Other Operating Activity | 170,169 | 24,564 | 24,338 | 18,452 | 3,636 |
| Operating Cash Flow | $-103,927 | $-47,134 | $-72,185 | $-72,235 | $-36,710 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -563,027 | -288,957 | -132,825 | -161,433 | 27,968 |
| PPE Investments | -36,173 | -18,717 | -20,203 | -6,681 | -1,766 |
| Net Acquisitions | N/A | -7,328 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -17,886 | -2,500 | N/A | N/A | N/A |
| Other Investing Activity | -17,886 | -2,568 | 0 | -2,302 | 0 |
| Investing Cash Flow | $-617,086 | $-317,570 | $-153,028 | $-170,416 | $26,202 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,132,750 | N/A | N/A | -25,844 | -379 |
| Debt Repayment | -174 | -127 | -443 | -244 | 4 |
| Common Stock Issued | 371,223 | 368,465 | 257,162 | 765 | 266 |
| Common Stock Repurchased | N/A | N/A | -172 | -7,222 | -100 |
| Other Financing Activity | -93,492 | -1,034 | 36,614 | 314,201 | 40,049 |
| Financing Cash Flow | $1,410,307 | $367,304 | $293,161 | $281,656 | $39,840 |
| Exchange Rate Effect | 455 | 84 | N/A | N/A | N/A |
| Beginning Cash Position | 143,228 | 140,544 | 72,596 | 33,591 | 4,259 |
| End Cash Position | 832,977 | 143,228 | 140,544 | 72,596 | 33,591 |
| Net Cash Flow | $689,749 | $2,684 | $67,948 | $39,005 | $29,332 |
| Free Cash Flow | |||||
| Operating Cash Flow | -103,927 | -47,134 | -72,185 | -72,235 | -36,710 |
| Capital Expenditure | -36,173 | -18,717 | -20,203 | -6,681 | -1,766 |
| Free Cash Flow | -140,100 | -65,851 | -92,388 | -78,916 | -38,476 |